HARBOR INVESTMENT ADVISORY, LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 101 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOR INVESTMENT ADVISORY, LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$1,630
-11.7%
8030.0%0.00%
Q2 2023$1,847
-24.1%
8030.0%0.00%
Q1 2023$2,433
+108.8%
803
+60.6%
0.00%
Q4 2022$1,165
+16.5%
5000.0%0.00%
Q3 2022$1,0000.0%5000.0%0.00%
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,000
-50.0%
5000.0%0.00%
Q4 2021$2,0000.0%5000.0%0.00%
Q3 2021$2,0000.0%5000.0%0.00%
Q2 2021$2,0000.0%5000.0%0.00%
Q1 2021$2,0000.0%5000.0%0.00%
Q4 2020$2,0000.0%5000.0%0.00%
Q3 2020$2,0000.0%500
-50.0%
0.00%
Q2 2020$2,000
+100.0%
1,0000.0%0.00%
Q1 2020$1,000
-66.7%
1,0000.0%0.00%
-100.0%
Q4 2019$3,0001,0000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 3,332,616$10,431,0002.35%
Think Investments LP 2,000,000$6,260,0001.16%
RTW INVESTMENTS, LP 5,978,355$18,712,0000.45%
COWEN AND COMPANY, LLC 472,649$1,479,0000.24%
CADENCE CAPITAL MANAGEMENT LLC 50,736$159,0000.04%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 41,700$131,0000.04%
Hudson Bay Capital Management LP 710,000$2,222,0000.03%
Ikarian Capital, LLC 115,000$360,0000.03%
MIRABELLA FINANCIAL SERVICES LLP 52,892$166,0000.02%
Secure Asset Management, LLC 10,000$31,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders